Furthermore, BBR promotes mitochondrial energy output and FAO by targeting peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and stimulates AMP-activated protein kinase (AMPK) signaling in podocytes in DKD (Li et al., 2014). Here, PPARGC1A is linked to diabetic kidney disease.